Intensity-Modulated Whole Abdominal Radiotherapy After Surgery and Carboplatin/Taxane Chemotherapy for Advanced Ovarian Cancer: Phase I Study

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1382-1389

  Rochet, Nathalie ^a   Sterzing, Florian ^a   Jensen, Alexandra D ^a   Dinkel, Julien ^b   Herfarth, Klaus K ^a   Schubert, Kai ^a   Eichbaum, Michael H ^a   Schneeweiss, Andreas ^a   Sohn, Christof ^a   Debus, Juergen ^a   Harms, Wolfgang ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Department of Radiation Oncology ^*  (Switzerland)

Author keywords

Consolidation treatment; Helical tomotherapy; Ovarian cancer; Step and shoot intensity modulated radiotherapy; Whole abdominal radiotherapy

Indexed keywords

HELICAL TOMOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; OVARIAN CANCERS; STEP-AND-SHOOT; WHOLE ABDOMINAL RADIOTHERAPY;

CHEMOTHERAPY; MILITARY OPERATIONS; RADIOTHERAPY; SURGERY;

TOXICITY;

CARBOPLATIN; DOCETAXEL; PACLITAXEL;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG SAFETY; DYSURIA; FEMALE; FOLLOW UP; HEART; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LEUKOPENIA; LIVER; LIVER METASTASIS; NAUSEA; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIC GIRDLE; PELVIS; PERITONEAL CAVITY; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; SMALL INTESTINE OBSTRUCTION; THROMBOCYTOPENIA; TOMOTHERAPY; TUMOR VOLUME; UTERINE TUBE CARCINOMA; VERTEBRA BODY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; DIARRHEA; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HEART; HUMANS; KIDNEY; LEUKOPENIA; LIVER; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC BONES; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; SPINE; THROMBOCYTOPENIA;

EID: 77949545684     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.061     Document Type: Article

References (46)

1. McGuire III W.P. Current status of taxane and platinum-based chemotherapy in ovarian cancer. J Clin Oncol 21 (2003) 133S-135S
2. Ozols R.F., Bundy B.N., Greer B.E., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21 (2003) 3194-3200
3. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 20 (2002) 1248-1259
4. Lambert H.E., Gregory W.M., Nelstrop A.E., et al. Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: Life expectancy compared to women of an age-matched normal population. Int J Gynecol Cancer 14 (2004) 772-778
5. Cannistra S.A., Bast Jr. R.C., Berek J.S., et al. Progress in the management of gynecologic cancer: Consensus summary statement. J Clin Oncol 21 (2003) 129S-132S
6. Donato M.L., Aleman A., Champlin R.E., et al. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 33 (2004) 1219-1224
7. Dufour P., Bergerat J.P., Barats J.C., et al. Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission. Cancer 73 (1994) 1865-1869
8. Varia M.A., Stehman F.B., Bundy B.N., et al. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: A randomized trial of the Gynecologic Oncology Group. J Clin Oncol 21 (2003) 2849-2855
9. Dembo A.J. Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience. Cancer 55 (1985) 2285-2290
10. Dembo A.J. Epithelial ovarian cancer: The role of radiotherapy. Int J Radiat Oncol Biol Phys 22 (1992) 835-845
11. Smith J.P., Rutledge F.N., and Delclos L. Postoperative treatment of early cancer of the ovary: A random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr 42 (1975) 149-153
12. Kapp K.S., Kapp D.S., Poschauko J., et al. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol 74 (1999) 400-407
13. Lambert H.E., Rustin G.J., Gregory W.M., et al. A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study. Ann Oncol 8 (1997) 327-333
14. MacGibbon A., Bucci J., MacLeod C., et al. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecol Oncol 75 (1999) 62-67
15. Pickel H., Lahousen M., Petru E., et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 72 (1999) 215-219
16. Thomas G.M. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer?. Gynecol Oncol 51 (1993) 97-103
17. Thomas G.M., and Dembo A.J. Integrating radiation therapy into the management of ovarian cancer. Cancer 71 (1993) 1710-1718
18. Sorbe B. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 13 (2003) 278-286
19. Einhorn N., Lundell M., Nilsson B., et al. Is there place for radiotherapy in the treatment of advanced ovarian cancer?. Radiother Oncol 53 (1999) 213-218
20. Einhorn N., Trope C., Ridderheim M., et al. A systematic overview of radiation therapy effects in ovarian cancer. Acta Oncol 42 (2003) 562-566
21. Fyles A.W., Thomas G.M., Pintilie M., et al. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer. Int J Radiat Oncol Biol Phys 41 (1998) 543-549
22. Fuller D.B., Sause W.T., Plenk H.P., et al. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 5 (1987) 897-905
23. Debus J., Zierhut D., Didinger B., et al. Inverse planning and intensity-modulated radiotherapy in patients with prostate cancer. Front Radiat Ther Oncol 36 (2002) 25-34
24. Rochet N., Sterzing F., Jensen A., et al. Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 184 (2008) 145-149
25. Duthoy W., De Gersem W., Vergote K., et al. Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): First clinical experience. Int J Radiat Oncol Biol Phys 57 (2003) 1019-1032
26. Hong L., Alektiar K., Chui C., et al. IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 54 (2002) 278-289
27. Mackie T.R., Holmes T., Swerdloff S., et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20 (1993) 1709-1719
28. Dembo A.J., and Bush R.S. Current concepts in cancer: Ovary-treatment of stages III and IV. Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys 8 (1982) 893-897
29. Rochet N., Jensen A.D., Sterzing F., et al. Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01): Pilot trial of a phase I/II study: study protocol. BMC Cancer 7 (2007) 227
30. Du B.A., Quinn M., Thigpen T., et al. 2004 consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 16 Suppl. 8 (2005) viii7-viii12
31. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. International Commission on Radiation Units and Measurements, Bethesda, Maryland.
32. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
33. Munter M.W., Thieke C., Nikoghosyan A., et al. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience. Lung Cancer 49 Suppl. 1 (2005) S83-S86
34. Kalli K.R. MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer. Curr Opin Investig Drugs 8 (2007) 1067-1073
35. Munter M.W., Thilmann C., Hof H., et al. Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 66 (2003) 313-321
36. Ledermann J.A., Dembo A.J., Sturgeon J.F., et al. Outcome of patients with unfavorable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation. Gynecol Oncol 41 (1991) 30-35
37. Whelan T.J., Dembo A.J., Bush R.S., et al. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int J Radiat Oncol Biol Phys 22 (1992) 853-858
38. Wong R., Milosevic M., Sturgeon J., et al. Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol. Int J Radiat Oncol Biol Phys 45 (1999) 657-665
39. Petit T., Velten M., d'Hombres A., et al. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy. Gynecol Oncol 104 (2007) 104-108
40. Fyles A.W., Dembo A.J., Bush R.S., et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys 22 (1992) 847-851
41. Dinniwell R., Lock M., Pintilie M., et al. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer. Int J Radiat Oncol Biol Phys 62 (2005) 104-110
42. Ellis H. The clinical significance of adhesions: Focus on intestinal obstruction. Eur J Surg Suppl (1997) 5-9
43. McEntee G., Pender D., Mulvin D., et al. Current spectrum of intestinal obstruction. Br J Surg 74 (1987) 976-980
44. Ellis H., Moran B.J., Thompson J.N., et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet 353 (1999) 1476-1480
45. Coia L.R., Myerson R.J., and Tepper J.E. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 31 (1995) 1213-1236
46. Firat S., Murray K., and Erickson B. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Int J Radiat Oncol Biol Phys 57 (2003) 201-207